Analysts at Citigroup bowed to the uncertainty surrounding Boston Scientific’s (NYSE:BSX) immediate financial future, delivering a downgrade to its stock rating as headwinds in its cardiac business are complicated by its recovery from a major cyberattack last month. Citi’s researchers have lowered their estimates for the company eight times so far this year, most recently […]
MassDevice Cardiovascular Hub
MassDevice's Cardiovascular Hub is your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Check out our latest feature:
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ MassDevice’s Cardio Device Companies Special Report
+ 12 things you need to know about the transcatheter heart valves market
+ The top cardiovascular tech stories out of TCT 2025
+ First Look: Boston Scientific’s next-gen Faraflex PFA and mapping catheter
+ How Abbott dialed in the waveform for its Volt PFA system
+ The top 10 cardiac device stories of 2024
+ The latest AI-powered cardiology devices you need to know
Latest Cardiology News
Johnson & Johnson drops LAA assets following suspended pivotal study
Johnson & Johnson MedTech (NYSE:JNJ) is offloading a left-atrial appendage closure system it paid $400 million upfront for nearly three years ago, abandoning plans to compete in the space dominated by Boston Scientific and Abbott. Acquired through its late-2023 buy of the developer Laminar, J&J’s Biosense Webster then backed a pivotal study that sought to […]
Medtronic hires former Recor CEO to run interventional cardiology group
Medtronic (NYSE:MDT) has hired former Recor Medical President and CEO Lara Barghout as president of the Interventional Cardiology Therapies (ICT) operating unit. The ICT business covers minimally invasive therapies in structural heart, coronary, and hypertension management, the last of which includes renal denervation (RDN). Watch on-demand: The 2026 MDO Min-Vasive Medtech webinar series Recor Medical won […]
Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker
Abbott (NYSE: ABT) announced today that the FDA has approved the smallest version yet of its Aveir leadless pacemakers. The Aveir VR Mini ventricular leadless pacemaker is 32.5 mm long, a 14% reduction from the 38.0 mm of the existing Aveir VR ventricular leadless pacemaker. According to Abbott, it designed the system to deliver longevity […]
Powerful Medical announces FDA De Novo nod for AI ECG and other extra medtech news
Powerful Medical today announced FDA De Novo authorization for its Queen of Hearts AI ECG model. According to New York–based Powerful Medical, the AI-powered model is meant to identify ECG findings suggestive of urgent acute coronary syndrome (ACS). The goal is to get urgent notifications to clinicians of suspected cases. According to Powerful Medical, the […]
Luma Vision wins expanded FDA nod for its cardiac procedure software
Luma Vision has won FDA clearance to expand the capabilities of its Verafeye cardiac ablation procedure intelligence platform. The privately held, Dublin, Ireland–based medtech plans to launch commercially in early 2027. The news comes about six months after the company said it was expanding its clinical programs after submitting to the FDA. “By bringing imaging, […]
Edwards Lifesciences, Medtronic score CMS win for TAVR
Edwards Lifesciences (NYSE: EW) and Medtronic (NYSE: MDT) are among the medtech companies praising CMS’s decision to expand Medicare coverage for TAVR to people with asymptomatic severe aortic stenosis. The finalized national coverage decision, published yesterday evening, also removes the evidence development (CED) requirement for symptomatic cases. In addition, CMS plans to review the evidence […]
Stryker still working through cyberattack after-effects, stock down more than 10% this week
Stryker (NYSE: SYK) stock plunged this week after its CFO said the orthopedic and surgical device giant is still managing supply disruptions after an Iran-backed cyberattack earlier this year. SYK shares are down more than 10% over the past five days, trading at around $273 apiece, though the stock was up more than 1% today. […]
Corcym achieves first-in-human implant of TriMemo for tricuspid valve repair
Corcym today announced that Cleveland Clinic doctors performed the first-in-human implantation of TriMemo, a semi-rigid ring designed to repair the tricuspid valve. The ring comprises three layers: a carbon film coating over the oval silicone sheath, which together guard the laser-cut nitinol cell structure. Nitinol, a superelastic nickel-titanium alloy, allows the device to flex with […]
Abbott earns FDA approval for new dual-energy ablation catheter
Abbott (NYSE: ABT) earned FDA approval for its new dual-energy catheter, TactiFlex Duo sensor-enabled ablation catheter. TactiFlex Duo joins Johnson & Johnson MedTech’s ThermoCool SmartTouch SF and Medtronic’s Affera Sphere-9 catheter in the U.S. dual-energy ablation catheter market. Medtronic won its Sphere-9 approval in 2024, and J&J earned FDA approval for its system in July […]
Medtronic says Endurant stent graft’s new CE mark could boost use for ruptured AAA
Medtronic (NYSE: MDT) has secured a CE mark for its Endurant stent graft, removing a treatment warning related to its use in ruptured abdominal aortic aneurysms (AAA). The Minnesota-run medtech giant received a similar FDA labeling change in late 2025. A ruptured AAA occurs when the main artery in the abdomen bursts, causing severe internal […]
